Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in AVXL — Anavex Life Sciences Corp.

CIK 1692234 Seattle, WA
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$60,838
+$41,375 QoQ
Shares Held
23,490
+270.5% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 179 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. AVXL ranks #222 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in AVXL

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $60,838 23,490
2026-03-31 $19,463 6,340
2025-12-31 $24,649 6,924
2025-09-30 $62,157 6,984
2025-06-30 $553 60
2025-03-31 $326 38
2024-03-31 $585 115
2023-12-31 $800 86
2023-03-31 $351,429 41,007
2022-12-31 $379,724 41,007
2022-09-30 $423,192 41,007
2022-06-30 $410,480 41,007
2022-03-31 $504,796 41,007
2021-12-31 $711,061 41,007
2021-09-30 $736,075 41,007
2021-06-30 $3,149,489 137,773
2021-03-31 $3,865,695 258,575
2020-12-31 $1,861,579 344,737
2020-09-30 $2,242,276 492,808
2020-06-30 $1,059,900 215,427
2020-03-31 $760,649 241,476